Related Experiment Video
Updated: Jun 26, 2025

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
An Age Group Comparison of Concurrent Hospice Care: A Cost-Effectiveness Analysis
Insights
Concurrent hospice care for pediatric patients reduces live discharges but increases Medicaid costs. It is most cost-effective for infants and young children under 5 years old.
Area of Science:
- Health Economics
- Pediatric Palliative Care
- Healthcare Management
Background:
- Standard hospice care is the typical approach for pediatric patients requiring end-of-life support.
- Concurrent hospice care offers simultaneous palliative and acute medical services, potentially altering patient outcomes and costs.
- Understanding the cost-effectiveness of concurrent care across different pediatric age groups is crucial for resource allocation.
Purpose of the Study:
- To evaluate the cost-effectiveness of concurrent hospice care versus standard hospice care for pediatric patients.
- To analyze these costs across four distinct pediatric age categories: <1 year, 1–5 years, 6–14 years, and 15–20 years.
- To determine age-specific incremental cost-effectiveness ratios (ICERs) for concurrent care.
Main Methods:
- Utilized a national Medicaid database encompassing 18,152 pediatric patients enrolled in hospice between 2011 and 2013.
- Calculated per-patient-per-month (PPPM) costs for hospice care across specified age groups.
- Analyzed incremental cost-effectiveness ratios (ICERs) comparing concurrent care to standard care for each age cohort.
Main Results:
- Concurrent hospice care resulted in fewer live discharges but incurred higher total Medicaid costs compared to standard care.
- The most cost-effective age groups for concurrent hospice care were <1 year ($45 ICER) and 1–5 years ($49 ICER).
- Older pediatric age groups (6–14 and 15–20 years) experienced significantly higher costs for concurrent care, with ICERs of $217 and $107, respectively.
Conclusions:
- Concurrent hospice care is effective in reducing live discharges among pediatric patients.
- The higher costs associated with concurrent care are most justifiable in the youngest pediatric age groups (<1 and 1–5 years).
- Healthcare providers and policymakers should consider age-specific data when deciding on the implementation of concurrent hospice care.
Abstract:
This study aimed to examine the cost-effectiveness of concurrent hospice care compared with standard care among pediatric patients of different age groups. Using a national Medicaid database of 18 152 pediatric patients enrolled in hospice care between 2011 and 2013, this study calculated and analyzed incremental cost-effectiveness ratios (ICERs) for concurrent care versus standard hospice care for children of 4 age categories: <1 year, 1 to 5 years, 6 to 14 years, and 15 to 20 years. The results indicated that the total Medicaid cost of hospice care was $3229 per patient per month (PPPM; SD, $8709) for those younger than 1 year, $4793 PPPM (SD, $8178) for those aged 1 to 5 years, $5411 PPPM (SD, $7456) for those aged 6 to 14 years, and $5625 PPPM (SD, $11459) for those aged 15 to 20 years. Incremental cost-effectiveness ratio values across all age groups showed that children enrolled in concurrent care had fewer live discharges but at a higher Medicaid cost of care as compared with those enrolled in standard hospice care. Concurrent hospice care was the most cost-effective in the age groups of <1 year and 1 to 5 years, with ICERs equal to $45 (95% confidence interval [CI], $23-$66) and $49 (95% CI, $8-$76), respectively. For the other older age groups, benefits of enrollment in concurrent care came at a much higher cost: in the age group of 6 to 14 years, ICER was equal to $217 (95% CI, $129-$217), and in the age group of 15 to 20 years, it was $107 (95% CI, $82-$183). Concurrent hospice is an effective way to reduce live discharges but has a higher total Medicaid cost than standard hospice care.
More Related Videos
06:16Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
Related Concept Videos
Continuing Care
Comparing the Survival Analysis of Two or More Groups
Documentation in Long-Term and Home Healthcare Setting
Long-Term Care Facilities
Hazard Ratio
For example, in a clinical trial...
Cancer Survival Analysis
Methods Of Healthcare Delivery System
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...